Page last updated: 2024-09-03

sr 48692 and Erythroderma, Sezary

sr 48692 has been researched along with Erythroderma, Sezary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bagot, M; Bensussan, A; Boumsell, L; Chalon, P; Culouscou, JM; Ferrara, P; Magazin, M; Poszepczynska-Guigné, E; Pruvost, C	1

Other Studies

1 other study(ies) available for sr 48692 and Erythroderma, Sezary

Article	Year
Sezary syndrome cells unlike normal circulating T lymphocytes fail to migrate following engagement of NT1 receptor. The Journal of investigative dermatology, 2004, Volume: 122, Issue:1 Topics: Actins; CD4-Positive T-Lymphocytes; Chemotaxis; Enzyme Inhibitors; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression; Humans; Jurkat Cells; Neurokinin-1 Receptor Antagonists; Neurotensin; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein-Tyrosine Kinases; Pyrazoles; Quinolines; Receptors, Neurokinin-1; Sezary Syndrome	2004

Article

Year

Sezary syndrome cells unlike normal circulating T lymphocytes fail to migrate following engagement of NT1 receptor.

The Journal of investigative dermatology, 2004, Volume: 122, Issue:1

Topics: Actins; CD4-Positive T-Lymphocytes; Chemotaxis; Enzyme Inhibitors; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression; Humans; Jurkat Cells; Neurokinin-1 Receptor Antagonists; Neurotensin; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein-Tyrosine Kinases; Pyrazoles; Quinolines; Receptors, Neurokinin-1; Sezary Syndrome

2004